Peregrine Pharmaceuticals reported $36.39M in Trade Creditors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Celldex Therapeutics CLDX:US USD 3.34M 1.07M
Immunogen IMGN:US USD 45.35M 25.17M
Intrexon XON:US USD 4.07M 133K
Macrogenics MGNX:US USD 4.9M 280K
Mannkind MNKD:US USD 11.05M 1.18M
Minerva Neurosciences NERV:US USD 970K 437K
Newlink Genetics NLNK:US USD 275K 435K
Novartis NOVN:VX USD 5.15B 453M
Novavax NVAX:US USD 216.52M 71.52M
Peregrine Pharmaceuticals PPHM:US USD 36.39M 13.06M
Repligen RGEN:US USD 27.55M 2.3M
Xencor XNCR:US USD 10.09M 4.53M